Skip to main content
. Author manuscript; available in PMC: 2014 Jun 6.
Published in final edited form as: Pharmacogenet Genomics. 2013 Nov;23(11):591–596. doi: 10.1097/FPC.0b013e32836533a5

Table 2.

The effect of ethnicity and genotype on nevirapine exposure

Ethnicity n Nevirapine AUC0–6h (mg/L*h)1 p
African American 6 18.3 ± 3.81 0.45
European American 12 22.5 ± 2.69

CYP2B6 516G>T African Americans

GG 1 4.23 ND
GT 5 21.2 ± 5.63
TT 0 -

European Americans

GG 4 20.5 ± 3.16 0.19
GT 5 20.3 ± 2.82
TT 3 28.8 ± 3.64

ABCB1 3435C>T African Americans

CC 2 7.31 ± 7.97 0.17
CT 4 23.8 ± 12.8

European Americans

CC 6 22.0 ± 3.03 0.96
CT 5 22.2 ± 3.32
1

Mean ± SEM